1. Home
  2. CRIS vs NTWK Comparison

CRIS vs NTWK Comparison

Compare CRIS & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • NTWK
  • Stock Information
  • Founded
  • CRIS 2000
  • NTWK 1997
  • Country
  • CRIS United States
  • NTWK United States
  • Employees
  • CRIS N/A
  • NTWK N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • CRIS Health Care
  • NTWK Technology
  • Exchange
  • CRIS Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • CRIS 22.9M
  • NTWK 56.1M
  • IPO Year
  • CRIS 2000
  • NTWK 1998
  • Fundamental
  • Price
  • CRIS $1.56
  • NTWK $4.50
  • Analyst Decision
  • CRIS Strong Buy
  • NTWK
  • Analyst Count
  • CRIS 2
  • NTWK 0
  • Target Price
  • CRIS $16.50
  • NTWK N/A
  • AVG Volume (30 Days)
  • CRIS 70.4K
  • NTWK 119.7K
  • Earning Date
  • CRIS 11-13-2025
  • NTWK 11-12-2025
  • Dividend Yield
  • CRIS N/A
  • NTWK N/A
  • EPS Growth
  • CRIS N/A
  • NTWK 316.67
  • EPS
  • CRIS N/A
  • NTWK 0.25
  • Revenue
  • CRIS $11,405,000.00
  • NTWK $66,088,229.00
  • Revenue This Year
  • CRIS $2.72
  • NTWK N/A
  • Revenue Next Year
  • CRIS $8.27
  • NTWK N/A
  • P/E Ratio
  • CRIS N/A
  • NTWK $18.00
  • Revenue Growth
  • CRIS 12.24
  • NTWK 7.65
  • 52 Week Low
  • CRIS $1.02
  • NTWK $2.14
  • 52 Week High
  • CRIS $5.45
  • NTWK $5.75
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 46.13
  • NTWK 48.69
  • Support Level
  • CRIS $1.44
  • NTWK $4.37
  • Resistance Level
  • CRIS $1.63
  • NTWK $4.63
  • Average True Range (ATR)
  • CRIS 0.11
  • NTWK 0.28
  • MACD
  • CRIS -0.01
  • NTWK -0.05
  • Stochastic Oscillator
  • CRIS 49.49
  • NTWK 22.73

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

Share on Social Networks: